BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of $166.53 million. The enterprise value is $102.92 million.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, before market open.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 37.74 million shares outstanding. The number of shares has decreased by -2.11% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 37.74M |
| Shares Change (YoY) | -2.11% |
| Shares Change (QoQ) | +16.92% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 24.11M |
Valuation Ratios
The trailing PE ratio is 57.01 and the forward PE ratio is 32.51.
| PE Ratio | 57.01 |
| Forward PE | 32.51 |
| PS Ratio | 4.06 |
| Forward PS | 0.89 |
| PB Ratio | 2.67 |
| P/TBV Ratio | 2.67 |
| P/FCF Ratio | 25.59 |
| P/OCF Ratio | 16.17 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 38.42, with an EV/FCF ratio of 15.81.
| EV / Earnings | 35.23 |
| EV / Sales | 2.51 |
| EV / EBITDA | 38.42 |
| EV / EBIT | 73.99 |
| EV / FCF | 15.81 |
Financial Position
The company has a current ratio of 5.19, with a Debt / Equity ratio of 0.09.
| Current Ratio | 5.19 |
| Quick Ratio | 4.85 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 1.78 |
| Debt / FCF | 0.86 |
| Interest Coverage | 1.12 |
Financial Efficiency
Return on equity (ROE) is 5.62% and return on invested capital (ROIC) is 1.58%.
| Return on Equity (ROE) | 5.62% |
| Return on Assets (ROA) | 1.11% |
| Return on Invested Capital (ROIC) | 1.58% |
| Return on Capital Employed (ROCE) | 1.76% |
| Revenue Per Employee | $306,090 |
| Profits Per Employee | $21,799 |
| Employee Count | 134 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.56 |
Taxes
In the past 12 months, BrainsWay has paid $538,000 in taxes.
| Income Tax | 538,000 |
| Effective Tax Rate | 15.55% |
Stock Price Statistics
The stock price has increased by +85.68% in the last 52 weeks. The beta is 0.16, so BrainsWay's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | +85.68% |
| 50-Day Moving Average | 9.59 |
| 200-Day Moving Average | 9.08 |
| Relative Strength Index (RSI) | 47.78 |
| Average Volume (20 Days) | 34,706 |
Short Selling Information
| Short Interest | 104,013 |
| Short Previous Month | 125,099 |
| Short % of Shares Out | 0.76% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.82 |
Income Statement
In the last 12 months, BrainsWay had revenue of $41.02 million and earned $2.92 million in profits. Earnings per share was $0.06.
| Revenue | 41.02M |
| Gross Profit | 30.58M |
| Operating Income | 1.39M |
| Pretax Income | 778,000 |
| Net Income | 2.92M |
| EBITDA | 2.68M |
| EBIT | 1.39M |
| Earnings Per Share (EPS) | $0.06 |
Full Income StatementBalance Sheet
The company has $69.35 million in cash and $5.62 million in debt, giving a net cash position of $63.72 million or $1.69 per share.
| Cash & Cash Equivalents | 69.35M |
| Total Debt | 5.62M |
| Net Cash | 63.72M |
| Net Cash Per Share | $1.69 |
| Equity (Book Value) | 62.31M |
| Book Value Per Share | 1.66 |
| Working Capital | 64.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $10.30 million and capital expenditures -$3.79 million, giving a free cash flow of $6.51 million.
| Operating Cash Flow | 10.30M |
| Capital Expenditures | -3.79M |
| Free Cash Flow | 6.51M |
| FCF Per Share | $0.17 |
Full Cash Flow StatementMargins
Gross margin is 74.56%, with operating and profit margins of 3.39% and 7.12%.
| Gross Margin | 74.56% |
| Operating Margin | 3.39% |
| Pretax Margin | 8.43% |
| Profit Margin | 7.12% |
| EBITDA Margin | 6.53% |
| EBIT Margin | 3.39% |
| FCF Margin | 15.87% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.11% |
| Shareholder Yield | 2.11% |
| Earnings Yield | 1.75% |
| FCF Yield | 3.91% |
Analyst Forecast
The average price target for BrainsWay is $13.17, which is 49.32% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.17 |
| Price Target Difference | 49.32% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BrainsWay has an Altman Z-Score of 2.17 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.17 |
| Piotroski F-Score | 6 |